Volume 91, Issue 2 pp. 192-202
Coronary Artery Disease

Towards a contemporary, comprehensive scoring system for determining technical outcomes of hybrid percutaneous chronic total occlusion treatment: The RECHARGE score

Joren Maeremans MSC

Joren Maeremans MSC

Faculty of Medicine and Life Sciences, Universiteit Hasselt, Hasselt, Belgium

Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium

Search for more papers by this author
James C. Spratt MD

James C. Spratt MD

Department of Cardiology, Forth Valley Royal Hospital, Edinburgh, United Kingdom

Search for more papers by this author
Paul Knaapen MD, PhD

Paul Knaapen MD, PhD

Department of Cardiology, VU university medical center, Amsterdam, the Netherlands

Search for more papers by this author
Simon Walsh MD

Simon Walsh MD

Department of Cardiology, Belfast City Hospital, Belfast, United Kingdom

Search for more papers by this author
Pierfrancesco Agostoni MD, PhD

Pierfrancesco Agostoni MD, PhD

Department of Cardiology, Universitair Medisch Centrum Utrecht, Utrecht, the Netherlands

Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands

Search for more papers by this author
William Wilson MBBS

William Wilson MBBS

Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia

Search for more papers by this author
Alexandre Avran MD

Alexandre Avran MD

Department of Cardiology, Clinique de Marignane, Marignane, Marseille, France

Search for more papers by this author
Benjamin Faurie MD, PhD

Benjamin Faurie MD, PhD

Department of Cardiology, Groupe Hospitalier Mutualiste, Grenoble, France

Search for more papers by this author
Erwan Bressollette MD

Erwan Bressollette MD

Department of Cardiology, Nouvelles Cliniques Nantaises, Nantes, France

Search for more papers by this author
Peter Kayaert MD

Peter Kayaert MD

Department of Cardiology, Universitair Ziekenhuis Brussel, Brussels, Belgium

Search for more papers by this author
Alan J. Bagnall MD, PhD

Alan J. Bagnall MD, PhD

Department of Cardiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom

Institute of Cellular Medicine, Newcastle University, United Kingdom

Search for more papers by this author
Dave Smith MD

Dave Smith MD

Department of Cardiology, Morriston Hospital, Swansea, United Kingdom

Search for more papers by this author
Margaret B. McEntegart MD, PhD

Margaret B. McEntegart MD, PhD

Department of Cardiology, Golden Jubilee National Hospital, Glasgow, United Kingdom

Search for more papers by this author
William H.T. Smith MD, BCHIR, PhD, FRCP

William H.T. Smith MD, BCHIR, PhD, FRCP

Department of Cardiology, Nottingham University Hospital, Nottingham, United Kingdom

Search for more papers by this author
Paul Kelly MD

Paul Kelly MD

Department of Cardiology, Essex Cardio-thoracic Centre, Basildon Hospital, Essex, United Kingdom

Search for more papers by this author
John Irving MD

John Irving MD

Department of Cardiology, Ninewells Hospital, Dundee, United Kingdom

Search for more papers by this author
Elliot J. Smith MD, FRCP

Elliot J. Smith MD, FRCP

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom

Search for more papers by this author
Julian W. Strange MD

Julian W. Strange MD

Department of Cardiology, Bristol Heart Institute, Bristol, United Kingdom

Search for more papers by this author
Jo Dens MD, PhD

Corresponding Author

Jo Dens MD, PhD

Faculty of Medicine and Life Sciences, Universiteit Hasselt, Hasselt, Belgium

Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium

Correspondence to: Jo Dens, MD, PhD; Schiepse Bos 6; 3600 Genk, Belgium. E-mail: [email protected]Search for more papers by this author
First published: 04 May 2017
Citations: 63

Disclosures/Conflicts of Interest: Jo Dens received grants from TopMedical (Distributor of Asahi Intecc co. materials), Boston Scientific, Vascular Solutions, and Orbus Neich for teaching courses and proctoring. Simon Walsh and James C Spratt are consultants for Abbott Vascular, Boston Scientific, Medtronic, and Vascular Solutions. Simon Walsh received research funding from Abbott Vascular, Boston Scientific, and Nitiloop. Paul Knaapen and Erwan Bressollette received honoraria from Boston Scientific for proctoring. Pierfrancesco Agostoni received institutional honoraria from Aquilant, Meril, Neovasc, Genae, and Angiodynamics. Alexandre Avran received grants form Abbott Vascular, Boston Scientific, and Biosensor for teaching courses and proctoring. John Irving is a proctor for Boston Scientific and Vascular Perspectives. Elliot Smith is proctor for Boston Scientific and receives honoraria from Vascular Solutions, Abbott Vascular, and Vascular Perspectives. Alan J. Bagnall received proctor and speaker fees from Abbott Vascular and Astra Zeneca. Benjamin Faurie is proctor for Boston Scientific and consultant for CORDIS. Paul Kelly is a member of the advisory board of Boston Scientific and Abbott Vascular. For the remaining authors, nothing was declared.

Abstract

Objectives

This study sought to create a contemporary scoring tool to predict technical outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) from patients treated by hybrid operators with differing experience levels.

Background

Current scoring systems need regular updating to cope with the positive evolutions regarding materials, techniques, and outcomes, while at the same time being applicable for a broad range of operators.

Methods

Clinical and angiographic characteristics from 880 CTO-PCIs included in the REgistry of CrossBoss and Hybrid procedures in FrAnce, the NetheRlands, BelGium and UnitEd Kingdom (RECHARGE) were analyzed by using a derivation and validation set (2:1 ratio). Variables significantly associated with technical failure in the multivariable analysis were incorporated in the score. Subsequently, the discriminatory capacity was assessed and the validation set was used to compare with the J-CTO score and PROGRESS scores.

Results

Technical success in the derivation and validation sets was 83% and 85%, respectively. Multivariate analysis identified six parameters associated with technical failure: blunt stump (beta coefficient (b) = 1.014); calcification (b = 0.908); tortuosity ≥45° (b = 0.964); lesion length 20 mm (b = 0.556); diseased distal landing zone (b = 0.794), and previous bypass graft on CTO vessel (b = 0.833). Score variables remained significant after bootstrapping. The RECHARGE score showed better discriminatory capacity in both sets (area-under-the-curve (AUC) = 0.783 and 0.711), compared to the J-CTO (AUC = 0.676) and PROGRESS (AUC = 0.608) scores.

Conclusions

The RECHARGE score is a novel, easy-to-use tool for assessing the risk for technical failure in hybrid CTO-PCI and has the potential to perform well for a broad community of operators. © 2017 Wiley Periodicals, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.